Celularity to acquire Alliqua BioMedical's wound care business for $29M

Alliqua BioMedical announced a definitive agreement for Celularity to acquire its advanced biologic wound care business and therapeutic ultrasound platform products for $29 million in cash. The transaction is subject to stockholder approval.

“This is a transformative transaction for Alliqua.”globenewswire.com

• 1 source
• globenewswire.comAlliqua BioMedical, Inc. Announces Definitive AssetAlliqua BioMedical, IncJan 5, 2018

Summarized from public sources; check the original articles before acting on it.